Loading...
NPI 1538208566 · Galax, VA · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Galax Treatment Center, Inc is a methadone clinic provider located in Galax, Virginia. This profile covers 4 Medicare and 20 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Galax Treatment Center, Inc |
| Address | 140 Larkspur Ln |
| City | Galax |
| State | VA |
| ZIP | 24333 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | February 6, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $14.1M |
| Medicare | $95.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 280 | $240 | $66.4K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services… | 70 | $190 | $12.7K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 330 | $40 | $11.8K |
| G2077 | Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and… | 40 | $110 | $4.5K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 4 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
20 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G9012 | Other specified case management service not elsewhere classified | 17,970 | $230 | $4M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 501,350 | $10 | $4M |
| S0109 | Methadone, oral, 5 mg | 379,880 | $10 | $1.9M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 50,260 | $40 | $1.8M |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 78,530 | $10 | $1M |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 75,810 | $10 | $606.5K |
| 80305 | The lab analyst performs presumptive drug test(s) by any method that the analyst can read by direct optical observation only, without instrument assistance, to screen for any number of drug classes… | 29,560 | $10 | $325.2K |
| J0571 | Buprenorphine, oral, 1 mg | 21,710 | $10 | $238.8K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 6,200 | $20 | $117.8K |
| H0010 | Alcohol and/or drug services; sub‑acute detoxification (residential addiction program inpatient) | 660 | $170 | $113.7K |
Showing 1–10 of 20
How this provider's Medicaid billing volume and revenue compare to other Virginia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Virginia median
20 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0010 | Alcohol and/or drug services; sub‑acute detoxification (residential addiction program inpatient) | 23 | 30 | 7,090 | $420 | $11.5M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 11 | 50 | 274,670 | $10 | $2.8M |
| S0109 | Methadone, oral, 5 mg | 19 | 50 | 177,970 | $10 | $1.7M |
| G9012 | Other specified case management service not elsewhere classified | 12 | 120 | 2,160 | $220 | $1.6M |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 4 | 20 | 5,660 | $20 | $459.6K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 3 | 100 | 3,280 | $40 | $455.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,615 | 3,520 | 370 | $70 | $280.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,033 | 4,010 | 290 | $50 | $199.8K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 1 | 10 | 3,250 | $10 | $158.8K |
| J0571 | Buprenorphine, oral, 1 mg | 2 | 10 | 11,370 | $10 | $141K |
Showing 1–10 of 20
Other providers in the same ZIP code as Galax Treatment Center, Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.